5 výsledky
The present invention is directed to the use of extracts or of extract compounds from Piper cubeba L. as active components in a medicament for the treatment of cancer.
Uses of Piper cubeba L. compositions are described for example in Hunnius, Pharmazeutisches Worterbuch, 8.sup.th edition, 1998,
BACKGROUND
Due to increasing incidence of cancer, in general, there is need to develop new therapeutic strategies. The current methods for treatment of tumors, besides radiation therapy and surgical interventions, include tumorcidal chemotherapeutic agents which act directly and are toxic to tumor
FIELD OF THE INVENTION
This application relates to tosylate salts of a lysine specific demethylase-1 (LSD1) inhibitor, including methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of LSD1 mediated diseases such as cancer.
BACKGROUND OF THE
FIELD OF THE INVENTION
This application relates to tosylate salts of a lysine specific demethylase-1 (LSD1) inhibitor, including methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of LSD1 mediated diseases such as cancer.
BACKGROUND OF THE
FIELD OF THE INVENTION
This invention relates to a method for providing .alpha.-glucosidase inhibition to a subject by administering a pharmaceutical composition comprising a .alpha.-glucosidase inhibitory agent selected from pipataline (formula 1a), sesamin (formula 1b), pellitorine (Formula 1c),